Cyon Therapeutics Inc.
Filing Date: December 21, 2017
Cyon Therapeutics Inc. (the “Company”) is a privately held clinical phase biotechnology company based in Vancouver, BC and conducted research in the University of British Columbia Department of Medicine relating to the clearance of bacterial toxins in patients with or at risk for sepsis. The Company filed a voluntary assignment in bankruptcy effective December 21, 2017 and MNP Ltd. was appointed as Licensed Insolvency Trustee of the bankrupt estate.